ATCO Pharma
人間用および動物用医薬品の製造
ATCO Pharma はエジプトでヒト用医薬品、動物用製品、飼料添加物を製造しています。同社は、国内および地域市場でヘルスケア、獣医薬、医薬品の流通チャネルを提供しています。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cairo, Egypt
- Founded
- 1999
- Website
- https://www.atcopharma.com.eg
- Categories
- 医療およびヘルスケア用品, 農業と原材料, 獣医製品と動物の健康
- Markets
- エジプト, サウジアラビア, アラブ首長国連邦
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- named-by-manufacturer (green), effective since 2026-07-03 Celltrion distributor list
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)